Company intelligence / Profile preview
Jagdale Industries
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
Overview
Jagdale Industries is actively running clinical trials, including Phase 3 studies of Botroclot for diabetic foot ulcers and surgical wounds and has marketed RTD (ready-to-drink) nutritional beverages for hydration, recovery, and chronic conditions. Their "Mulmina Apple" nutraceutical completed a controlled ADHD study in children
- Therapeutic areas
- EndocrinologyPsychiatryOther
- Modalities
- Small moleculeProtein (serine proteinases/hemocoagulase formulation)NutraceuticalHealth supplementBeverage
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Jagdale Industries.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jagdale Industries.